Abstract
Compound-3 is an oral monophosphate prodrug of gemcitabine. Previous data showed that Compound-3 was more potent than gemcitabine and it was orally active in a tumor xenograft model. In the present study, the metabolism of Compound-3 was investigated in several well-known in vitro matrices. While relatively stable in human and rat plasma, Compound-3 demonstrated noticeable metabolism in liver and intestinal microsomes in the presence of NADPH and human hepatocytes. Compound-3 could also be hydrolyzed by alkaline phosphatase, leading to gemcitabine formation. Metabolite identification using accurate mass- and information-based scan techniques revealed that Compound-3 was subjected to sequential metabolism, forming alcohol, aldehyde and carboxylic acid metabolites, respectively. Results from reaction phenotyping studies indicated that cytochrome P450 4F2 (CYP4F2) was a key CYP isozyme involved in Compound-3 metabolism. Interaction assays suggested that CYP4F2 activity could be inhibited by Compound-3 or an antiparasitic prodrug pafuramidine. Because CYP4F2 is a key CYP isozyme involved in the metabolism of eicosanoids and therapeutic drugs, clinical relevance of drug-drug interactions mediated via CYP4F2 inhibition warrants furth...Continue Reading
References
Sep 3, 1999·Journal of Clinical Pharmacology·B DavitL J Lesko
Aug 24, 2006·Pharmacology & Therapeutics·Auinash Kalsotra, Henry W Strobel
Sep 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael Zhuo WangJames Edwin Hall
Aug 22, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael Zhuo WangMary F Paine
Feb 14, 2009·Scandinavian Journal of Gastroenterology·Roland AnderssonMarit L Sandvold
Aug 31, 2010·The Journal of Biological Chemistry·Eisuke MurakamiPhillip A Furman
Sep 18, 2010·Journal of Medicinal Chemistry·Michael J SofiaPhillip A Furman
Nov 4, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yi JinChristopher J Patten
Sep 18, 2012·Molecular Pharmaceutics·Elodie MoysanJean-Pierre Benoit
Jun 1, 2013·Nature Reviews. Drug Discovery·Lars Petter JordheimCharles Dumontet
Oct 22, 2013·Biochemistry·Katheryne Z EdsonAllan E Rettie
Dec 5, 2013·Pharmaceutics·Enaksha WickremsinheEverett Perkins
Jan 30, 2014·Journal of Medicinal Chemistry·Magdalena SlusarczykChristopher McGuigan
Feb 11, 2014·The Journal of Antimicrobial Chemotherapy·Martin MarkowitzWilliam A Lee
May 13, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Scott Michaels, Michael Zhuo Wang
Oct 10, 2014·Biochemistry·Logan D AndrewsDaniel Herschlag
Dec 9, 2014·Chemical Research in Toxicology·Slobodan Rendic, F Peter Guengerich
Mar 21, 2016·Journal of Pharmaceutical Sciences·Huixin QiHongjian Zhang
Apr 6, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Hugh TilsonDaniel C Malone
Aug 18, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ravindra Dhar DubeyPrem N Gupta
Aug 10, 2017·Journal of Medicinal Chemistry·Youcef MehellouJan Balzarini
Oct 17, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hanadi SinokrotRafik Karaman
Citations
May 24, 2019·Chemical Communications : Chem Comm·Yuan MaChuan Zhang
Mar 4, 2020·Cell Communication and Signaling : CCS·Ping WangXueying Sun
Sep 5, 2019·International Journal of Molecular Sciences·Yazun Bashir Jarrar, Su-Jun Lee